Skip to main content
SpringerLink
Log in

Reversing effects of traditional Chinese antitumor medicines on colorectal tumor immunosuppression of natural killer cell and T lymphocyte in vitro

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

Reversing effects of traditional Chinese medicines on colorectal tumor immunosuppressions of natural killer (NK) cell and T lymphocyte were analyzed to provide evidence on selecting medicines for patients according to the different types of tumor immunosuppression.

Methods

Six traditional Chinese medicines, including Arsenious acid (AS), Ligustrazine hydrochloride (LHC), Astragalus mongholicus bge (AMB), Matrine N-oxide (MOX), Polyporus umbellatus polysaccharide (PUPS) and Artesunate (ART), were enrolled. The reversing effects on suppression of murine splenocyte transformation and NK killing activity were measured by 3-{4,5-dimethyl-2-thiazolyl}-2,5-diphenyl tetrazolium (MTT), and the effects on the suppressed expression of interleukin 2 receptor α (IL-2Rα), CD3ɛ+ξ+ and CD3ɛ−ξ+ were detected by flow cytometry (FCM). The effects on immunosuppressive molecules were measured by enzyme linked immunosorbent assay (ELISA), including transforming growth factor β1 (TGF-β1), vascular endothelial growth factor (VEGF), interleukin 4 (IL-4), IL-6, IL-10 and prostaglandin (PG) E2.

Results

(1) The reversing effects of AMB on the inhibition of NK killing and CD3ɛ+ξ+ expression were the most significant; the effect of LHC on inhibition of CD3ɛ−ξ+ expression was the strongest; the effects of AMB, PUPS and ART on inhibition of transformation were the greatest; and the effect of ART on inhibition of IL-2Rα expression was the strongest. (2) The correlated molecules of these medicines that exerted reversing effects on colorectal tumor immunosuppression were TGF-β1 and IL-10. AMB had the highest down-regulating effect on the secretion of TGF-β1. AS and ART had the highest effects on IL-10.

Conclusion

Reversing tumor immunosuppression through the down-regulation of immunosuppressive molecules is one of the novel antitumor mechanisms of traditional Chinese medicines. The clinical use of compounded prescriptions of ART combined with AMB and LHC should be considered to avoid the reduced treatment efficiency caused by tumor immunosuppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hsieh CL, Chen DS, Hwang LH. Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum Gene Ther, 2000, 11: 681–692.

    Article  PubMed  CAS  Google Scholar 

  2. Liu P, Jaffar J, Zhou Y, et al. Inhibition of TGFbeta1 makes nonimmunogenic tumor cells effective for therapeutic vaccination. J Immunother, 2009, 32: 232–239.

    Article  PubMed  CAS  Google Scholar 

  3. Zloza A, Jagoda MC, Lyons GE, et al. CD8 co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-beta (TGFbeta)-mediated suppression. Cancer Immunol Immunother, 2011, 60: 291–297.

    Article  PubMed  CAS  Google Scholar 

  4. Jarnicki AG, Lysaght J, Todryk S, et al. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol, 2006, 177: 896–904.

    PubMed  CAS  Google Scholar 

  5. Cahlin C, Lönnroth C, Arvidsson A, et al. Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content. Int J Oncol, 2008, 32: 909–918.

    PubMed  CAS  Google Scholar 

  6. Ksendzovsky A, Feinstein D, Zengou R, et al. Investigation of immunosuppressive mechanisms in a mouse glioma model. J Neurooncol, 2009, 93: 107–114.

    Article  PubMed  CAS  Google Scholar 

  7. Cheng HL, Tian DA, Hu XD, et al. The expression of TGF-β1, ADAM12 and HB-EGF in primary hepatic carcinoma. Chinese-German J Clin Oncol, 2008, 7: 686–689.

    Article  CAS  Google Scholar 

  8. Sredni B, Weil M, Khomenok G, et al. Ammonium trichloro (dioxoethylene-o,o’) tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res, 2004, 64: 1843–1852.

    Article  PubMed  CAS  Google Scholar 

  9. Mazzocca A, Fransvea E, Dituri F, et al. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology, 2010, 51: 523–534.

    Article  PubMed  CAS  Google Scholar 

  10. Llopiz D, Dotor J, Casares N, et al. Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy. Int J Cancer, 2009, 125: 2614–2623.

    Article  PubMed  CAS  Google Scholar 

  11. Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet, 2011, 378: 2081–2087.

    Article  PubMed  Google Scholar 

  12. Orido T, Fujino H, Kawashima T, et al. Decrease in uptake of arachidonic acid by indomethacin in LS174T human colon cancer cells; a novel cyclooxygenase-2-inhibition-independent effect. Arch Biochem Biophys, 2010, 494: 78–85.

    Article  PubMed  CAS  Google Scholar 

  13. Liu B, Wen JK, Li BH, et al. Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. Cell Death Dis, 2011, 2: e185.

    Article  PubMed  CAS  Google Scholar 

  14. Oshima M, Murai N, Kargman S, et al. Chemoprevention of intestinal polyposis in the Apcdelta 716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res, 2001, 61: 1733–1740.

    PubMed  CAS  Google Scholar 

  15. Fujimura T, Ohta T, Oyama K, et al. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer, 2007, 38: 78–82.

    Article  PubMed  CAS  Google Scholar 

  16. Haga N, Fujita N, Tsuruo T. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells. Cancer Sci, 2005, 96: 825–833.

    Article  PubMed  CAS  Google Scholar 

  17. Chen L, Lu Y, Wu JM, et al. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by vascular endothelial growth factor. Biochem Biophys Res Commun, 2009, 386: 374–379.

    Article  PubMed  CAS  Google Scholar 

  18. Tin MM, Cho CH, Chan K, et al. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis, 2007, 28: 1347–1355.

    Article  PubMed  CAS  Google Scholar 

  19. Ma L, Wen S, Zhan Y, et al. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med, 2008, 74: 245–251.

    Article  PubMed  CAS  Google Scholar 

  20. Efferth T, Briehl MM, Tome ME. Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol, 2003, 23: 1231–1235.

    PubMed  CAS  Google Scholar 

  21. Li J, Li QW, Gao DW, et al. Antitumor and immunomodulating effects of polysaccharides isolated from Solanum nigrum Linne. Phytother Res, 2009, 23: 1524–1530.

    Article  PubMed  CAS  Google Scholar 

  22. Luo C, Zhong HJ, Zhu LM, et al. Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism. Mol Biol Rep, 2012, 39: 5459–5464.

    Article  PubMed  CAS  Google Scholar 

  23. Mok TS, Yeo W, Johnson PJ, et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Ann Oncol, 2007, 18: 768–774.

    Article  PubMed  CAS  Google Scholar 

  24. Liu XH, Li J, Li QX, et al. Protective effects of ligustrazine on cisplatininduced oxidative stress, apoptosis and nephrotoxicity in rats. Environ Toxicol Pharmacol, 2008, 26: 49–55.

    Article  PubMed  CAS  Google Scholar 

  25. Koehler H, Kofler D, Hombach A, et al. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Cancer Res, 2007, 67: 2265–2273.

    Article  PubMed  CAS  Google Scholar 

  26. Fukuyama T, Ichiki Y, Yamada S, et al. Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci, 2007, 98: 1048–1054.

    Article  PubMed  CAS  Google Scholar 

  27. Hanaoka N, Jabri B, Dai Z, et al. NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease. J Immunol, 2010, 185: 5732–5742.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Training, Bethune Military Medical College, Shijiazhuang, 050081, China

    Cheng Cui, Aixia Zhang, Jianjun Hu, Wenguang Zheng, Zhanjiang Fu & Lirong Qi

  2. Department of Immunology, Basic Medical College, Hebei Medical University, Shijiazhuang, 050017, China

    Meixiang Li & Wei Lv

Authors
  1. Cheng Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aixia Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianjun Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wenguang Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhanjiang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lirong Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Meixiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wei Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheng Cui.

Additional information

Supported by grants from Hebei Province Nature Science Foundation (No. H2012509001) and Hebei Province Science & Technology Supporting Foundation (No. 092061111D).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cui, C., Zhang, A., Hu, J. et al. Reversing effects of traditional Chinese antitumor medicines on colorectal tumor immunosuppression of natural killer cell and T lymphocyte in vitro. Chin. -Ger. J. Clin. Oncol. 11, 721–731 (2012). https://doi.org/10.1007/s10330-012-1079-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-012-1079-5

Key words

Search

Navigation